Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU

被引：0
作者：
Roberta Joppi
Vittorio Bertele’
Silvio Garattini
机构：
[1] Mario Negri Institute for Pharmacological Research,Laboratory of Drug Regulatory Policies
[2] Local Health Unit of Verona,Pharmaceutical Department
来源：
European Journal of Clinical Pharmacology | 2013年 / 69卷
关键词：
Orphan drug; Rare disease; Pharmacological research; Drug regulation; Development; Preclinical studies; Clinical trials; Clinical efficacy; Placebo; Outcome measures;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1009 / 1024
页数：15
相关论文
共 50 条
  • [41] Orphan diseases: Evaluations of new treatments
    Bergmann, J. -F.
    Delcey, V.
    Champion, K.
    [J]. REVUE DE MEDECINE INTERNE, 2007, 28 : S202 - S205
  • [42] Orphan drug policies and use in pediatric nephrology
    Karpman, Diana
    Hoglund, Peter
    [J]. PEDIATRIC NEPHROLOGY, 2017, 32 (01) : 1 - 6
  • [43] The Reform of the Orphan Drug Assessment System in China
    Wang, Xiangyu
    Wang, Lin
    Zheng, Xiaoying
    Zheng, Qiang
    [J]. JOURNAL OF PHARMACEUTICAL INNOVATION, 2022, 17 (03) : 1062 - 1068
  • [44] Clinical trials of orphan drugs in China over the decade 2012-2022: Opportunities and challenges
    Wu, Xiaofei
    Xu, Wen
    Yu, Mengyang
    Zhang, Fan
    Wang, Hongyun
    [J]. PHARMACOLOGICAL RESEARCH, 2022, 182
  • [45] Orphan diseases: impact for anesthesia practice
    Prottengeier, Johannes
    Weith, Thomas
    Muenster, Tino
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2015, 28 (06) : 691 - 696
  • [46] Ethical Questions Linked to Rare Diseases and Orphan Drugs - A Systematic Review
    Kacetl, Jaroslav
    Maresova, Petra
    Maskuriy, Raihan
    Selamat, Ali
    [J]. RISK MANAGEMENT AND HEALTHCARE POLICY, 2020, 13 : 2125 - 2148
  • [47] Orphan Drug Legislation with Data Fusion Rules Using Multiple Fingerprints Measurements
    Zein, Moustafa
    Abdo, Ahmed
    Adl, Ammar
    Hassanien, Aboul Ella
    Tolba, Mohamed F.
    Snasel, Vaclav
    [J]. PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON INNOVATIONS IN BIO-INSPIRED COMPUTING AND APPLICATIONS (IBICA 2014), 2014, 303 : 261 - 270
  • [48] Pricing and reimbursement of orphan drugs: the need for more transparency
    Steven Simoens
    [J]. Orphanet Journal of Rare Diseases, 6
  • [49] Orphan drug: Development trends and strategies
    Sharma, Aarti
    Jacob, Abraham
    Tandon, Manas
    Kumar, Dushyant
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2010, 2 (04): : 290 - 299
  • [50] AN ORPHAN DRUG FRAMEWORK (ODF) FOR CANADA
    Lee, David K.
    Wong, Barbara
    [J]. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2014, 21 (01): : E42 - E46
12345